Search

Importer of Controlled Substances Application: Lipomed/LGC Standards

The Drug Enforcement Administration published a notice of application by Lipomed/LGC Standards for registration as an importer of controlled substances. The notice invites public comments on the application before a final registration decision is made. Comments must be submitted within 31 days of the publication date.

Bulk Manufacturer of Controlled Substances Application: Research Triangle Institute

DEA published notice that Research Triangle Institute has applied to become a bulk manufacturer of controlled substances. The notice opens a 60-day public comment period ending June 2, 2026. This is a routine application notice, not an approval or denial.

Bulk Manufacturer of Controlled Substances Application: Purisys LLC

The Drug Enforcement Administration published a notice of application from Purisys, LLC to register as a bulk manufacturer of controlled substances. The notice is published pursuant to 21 U.S.C. 823 and invites public comment on the application. Comments must be submitted within 60 days of the publication date.

Bulk Manufacturer of Controlled Substances Application: Royal Emerald Pharmaceuticals

The DEA published a notice that Royal Emerald Pharmaceuticals applied to register as a bulk manufacturer of Schedule I controlled substances including Marihuana Extract (7350), Marihuana (7360), and Tetrahydrocannabinols (7370) at its facility in Desert Hot Springs, California. The company proposes to provide cannabis botanical raw material and active pharmaceutical ingredients (API) to DEA-registered researchers and manufacturers. Public comments on the application are due June 1, 2026.

Controlled Substance Importer Application: Fisher Clinical Services

The Drug Enforcement Administration published a notice that Fisher Clinical Services, Inc. applied to be registered as an importer of a Schedule I controlled substance (3,4-Methylenedioxymethamphetamine, Drug Code 7405). The company plans to use the substance for clinical trials only. Registered manufacturers and applicants may submit comments or objections on or before May 1, 2026.

Controlled Substance Importer Application - Fisher Clinical Services

The DEA published a notice that Fisher Clinical Services, Inc. has applied to be registered as an importer of controlled substances. The application covers 3,4-Methylenedioxy-methamphetamine (MDMA, Schedule I, Drug Code 7405) for clinical trials only. The public comment period closes May 1, 2026.

Indivior Manufacturing LLC Controlled Substances Importer Application

The Drug Enforcement Administration published notice that Indivior Manufacturing LLC (Raleigh, NC) applied to be registered as an importer of Thebaine (drug code 9333, Schedule II controlled substance). The company plans to import the controlled substance for research, clinical trials, analytical purposes, and manufacturing process development. The public comment period closes May 1, 2026.

Sterling Wisconsin LLC, controlled substances importer application

The Drug Enforcement Administration published a notice that Sterling Wisconsin, LLC applied to be registered as an importer of controlled substances (Drug Code 7431 - 5-Methoxy-N,N-dimethyltryptamine, Schedule I). The company plans to import this substance as bulk Active Pharmaceutical Ingredient for internal research, clinical investigational studies, and analytical purposes. Comments on the application are due May 1, 2026.

Bulk Manufacturer of Controlled Substances Application: Pharmaron Manufacturing Services (US) LLC

The DEA published a notice that Pharmaron Manufacturing Services (US) LLC applied on February 10, 2026 to be registered as a bulk manufacturer of Schedule II controlled substances (Oxycodone, Thebaine, Oxymorphone, and Noroxymorphone) at its facility in Coventry, Rhode Island. The company plans to produce material for clinical trials only. The public has until June 1, 2026 to submit comments or objections to the application.

Importer of Controlled Substances Application: Research Triangle Institute

The DEA published notice that Research Triangle Institute applied to be registered as an importer of Schedule I controlled substances, including cathinone derivatives and synthetic stimulants. The application covers basic class(es) of controlled substances listed in the Federal Register. Interested parties may submit comments or objections, or request a hearing on the application.